Neurizon Therapeutics Limited has released a press release.
Reinstatement to Official Quotation
Filed with ASX ·
6ix hasn’t read this filing yet.
Neurizon Therapeutics Limited on 6ix
Story so far
Earlier from Neurizon Therapeutics
- Confirmation of Preliminary COVID-19 Results
- Voluntary Suspension
- Virtual Investor Briefing Presentation
- Preliminary Positive Results for the Treatment of SARS-CoV-2
- Suspension from Official Quotation
Later from Neurizon Therapeutics
- Inhibition of SARS-CoV-2 by MPL in Human Respiratory Cells
- Appendix 4E & Preliminary Final Report
- Epichem in partnership to develop waste into fuel technology
- Elanco Option Update
- Monepantel Anti-viral Activity Against SARS-CoV-2 Confirmed
Follow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics